INTERNATIONAL BIOTECHNOLOGY TRUST PLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 249 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.5%.

Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$11,810,482
+465.3%
129,700
+309.1%
3.60%
+516.6%
Q1 2023$2,089,347
+27.5%
31,7000.0%0.58%
+15.2%
Q4 2022$1,638,256
-95.0%
31,700
+2056.5%
0.51%
+49.3%
Q2 2022$32,500,000
+2015.9%
1,470
-95.5%
0.34%
-2.0%
Q1 2022$1,536,0000.0%32,5000.0%0.35%
+1.2%
Q4 2021$1,536,000
+4.1%
32,500
+38.9%
0.34%
-12.3%
Q2 2021$1,476,000
+47.5%
23,4000.0%0.39%
+47.2%
Q1 2021$1,001,00023,4000.26%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 624,962$20,599,00013.29%
Octagon Capital Advisors LP 1,595,911$52,601,00012.95%
Logos Global Management LP 1,450,000$47,792,0003.45%
Avoro Capital Advisors LLC 5,000,000$164,800,0002.59%
Ghost Tree Capital, LLC 200,000$6,592,0001.93%
Integral Health Asset Management, LLC 190,000$6,262,0001.80%
GREAT POINT PARTNERS LLC 200,000$6,592,0001.54%
Aufman Associates Inc 53,642$1,768,0001.45%
Ghost Tree Capital, LLC 150,000$4,944,0001.45%
Altium Capital Management LP 166,700$5,494,0001.44%
View complete list of APELLIS PHARMACEUTICALS INC shareholders